| Adam Kuzma, CRNA | |
|
250 Park St, Bowling Green, KY 42101-1760 | |
| (270) 393-1912 | |
| (270) 393-1913 |
| Full Name | Adam Kuzma |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 250 Park St, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104252824 | NPI | - | NPPES |
| 7100271990 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3008438 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Medical Center (bowling Green) | Bowling green, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Commonwealth Health Corporation Inc | 5496667628 | 221 |
News Archive
Cognitive performance of adolescent girls who walk to school is better than that of girls who travel by bus or car. Moreover, cognitive performance is also better in girls who take more than 15 minutes than in those who live closer and have a shorter walk to school.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.
An international collaboration led by veterinary scientists at Tokyo University of Agriculture and Technology, Japan, has found that size of a dog heart affects both vortex flow and pressure difference in the heart, which both are promising as an index of diastolic function.
New research has found that bariatric surgery is an effective way to control weight in morbidly obese patients who are at risk for developing atrial fibrillation (AF).
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
› Verified 8 days ago
| Entity Name | Commonwealth Health Corporation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881109304 PECOS PAC ID: 5496667628 Enrollment ID: O20040916000800 |
News Archive
Cognitive performance of adolescent girls who walk to school is better than that of girls who travel by bus or car. Moreover, cognitive performance is also better in girls who take more than 15 minutes than in those who live closer and have a shorter walk to school.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.
An international collaboration led by veterinary scientists at Tokyo University of Agriculture and Technology, Japan, has found that size of a dog heart affects both vortex flow and pressure difference in the heart, which both are promising as an index of diastolic function.
New research has found that bariatric surgery is an effective way to control weight in morbidly obese patients who are at risk for developing atrial fibrillation (AF).
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
› Verified 8 days ago
| Entity Name | Lifelinc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801021464 PECOS PAC ID: 0941347447 Enrollment ID: O20140522001233 |
News Archive
Cognitive performance of adolescent girls who walk to school is better than that of girls who travel by bus or car. Moreover, cognitive performance is also better in girls who take more than 15 minutes than in those who live closer and have a shorter walk to school.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.
An international collaboration led by veterinary scientists at Tokyo University of Agriculture and Technology, Japan, has found that size of a dog heart affects both vortex flow and pressure difference in the heart, which both are promising as an index of diastolic function.
New research has found that bariatric surgery is an effective way to control weight in morbidly obese patients who are at risk for developing atrial fibrillation (AF).
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Kuzma, CRNA 825 2nd Avw, Suite C6, Bowling Green, KY 42101 Ph: (270) 393-1912 | Adam Kuzma, CRNA 250 Park St, Bowling Green, KY 42101-1760 Ph: (270) 393-1912 |
News Archive
Cognitive performance of adolescent girls who walk to school is better than that of girls who travel by bus or car. Moreover, cognitive performance is also better in girls who take more than 15 minutes than in those who live closer and have a shorter walk to school.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.
An international collaboration led by veterinary scientists at Tokyo University of Agriculture and Technology, Japan, has found that size of a dog heart affects both vortex flow and pressure difference in the heart, which both are promising as an index of diastolic function.
New research has found that bariatric surgery is an effective way to control weight in morbidly obese patients who are at risk for developing atrial fibrillation (AF).
United Therapeutics Corporation announced today that the United States Food and Drug Administration has approved Unituxin (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
› Verified 8 days ago
Christian Michael Kranz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-393-1912 Fax: 270-393-1913 | |
Cody S. Campbell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 350 Park St, Suite 203b, Bowling Green, KY 42101 Phone: 270-393-1912 Fax: 270-393-1913 | |
Miss Heather G Childress, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 350 Park St, Suite 203b, Bowling Green, KY 42101 Phone: 270-393-1912 Fax: 270-393-1913 | |
Kristin K Bateman, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-393-1912 Fax: 270-393-1913 | |
Bruce Scott Weickel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-745-1000 Fax: 270-393-1913 | |
Meagan Nicole Moore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 250 Park St, Bowling Green, KY 42101 Phone: 270-745-1000 |